The growing interest in successful weight management has spurred considerable research into novel treatments. Recently , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has shown positive results in patient trials, indicating potential for substantial weight reduction . Consequently , many individual